Journals / Nöropsikiyatri Arşivi / 2014 / Cilt: 51 - Sayı: 2

The influence of vitamin d treatment on the ınducible nitric oxide synthase (ınos) expression in primary hippocampal neurons

Vitamin d uygulamasının primer hippokampal nöronlardaki indüklenebilir nitrik oksit sentaz (inos) anlatımı üzerine etkileri

Pages
163–168
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conc­lu­si­on: Our results indicated that vitamin D has the potential to prevent oxidative damage by suppressing iNOS expression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Neurodegeneration is a process that is characterized by the loss of neuronal structure and function and eventually ends with neuronal death.
📊
Key Findings & Data:Met­hod: Twenty four and 48 hours of vitamin D treatments were performed on primary hippocampal neuron cultures that were prepared from Sprague dawley rat embryos (E18).
💡
Conclusion & Impact:Conc­lu­si­on: Our results indicated that vitamin D has the potential to prevent oxidative damage by suppressing iNOS expression.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Neurodegeneration is a process that is characterized by the loss of neuronal structure and function and eventually ends with neuronal death. An elevated level of inducible nitric oxide synthase (iNOS) is suggested to accompany this process by inducing oxidative and nitrosative damage. Vitamin D is reported to protect glial cells against neurotoxicity via suppressing iNOS synthesis. Though there was no data about whether iNOS is regulated by vitamin D in hippocampal neurons. In this study our aim was to determine any alteration in iNOS expression of hippocampal neurons in response to vitamin D treatment. Met­hod: Twenty four and 48 hours of vitamin D treatments were performed on primary hippocampal neuron cultures that were prepared from Sprague dawley rat embryos (E18). The alterations in the iNOS mRNA expression were determined with quantative real time polymerase chain reaction (qRT-PCR). The cytotoxicity levels of each group were investigated by the measurement of lactate dehydrogenase (LDH) that is released to culture medium. Re­sults: No difference was observed between groups in 24 hours of treatment regarding the iNOS expression. Though the iNOS mRNA level of vitamin D treated group was significantly lower than that of control group on the 48th hours of treatment (p<0.001). Vitamin D treatment also attenuated the LDH release which is an indicator of cytotoxicity (p<0.001). Conc­lu­si­on: Our results indicated that vitamin D has the potential to prevent oxidative damage by suppressing iNOS expression.

Özet

Giriş: Nörodejenerasyon, sinir hücrelerinin yapı ve fonksiyonlarını kaybetmesine bağlı olarak nöron ölümü ile sonuçlanan bir süreçtir. Bu süreçte artan indüklenebilir nitrik oksit sentaz (iNOS) seviyelerinin, hücrelerin oksidatif ve nitrozatif hasarına sebep olarak nörodejenerasyona eşlik ettiği düşünülmektedir. Vitamin D’nin ise glia hücrelerinde iNOS sentezini baskılayarak hücreleri nörotoksisiteye karşı koruduğu ileri sürülmektedir. Ancak iNOS’un hippokampal nöronlarda vitamin D tarafından düzenlenip düzenlenmediğini gösteren herhangi bir çalışma yoktur. Bu çalışmadaki amacımız, hippokampal nöronların vitamin D uygulamasına cevap olarak iNOS anlatımlarında bir değişiklik olup olmadığını belirlemektir. Yön­tem­: Sprague dawley cinsi sıçanların 18 günlük embriyolarının hippokampuslarından hazırlanan primer nöron kültürlerine 24 ve 48 saat süre ile vitamin D uygulandı. iNOS mRNA miktarlarındaki değişimler kantitatif gerçek zamanlı polimeraz zincir reaksiyonu (qRT-PCR) yöntemi ile belirlendi. Tüm grupların sitotoksisite seviyeleri kültür medyumuna salınan laktat dehidrogenazın (LDH) ölçülmesi ile belirlendi. Bul­gu­lar: Yirmi dört saat boyunca vitamin D uygulanan grupla diğer gruplar arasında herhangi bir iNOS anlatımı açısından bir fark gözlenmezken, 48 saat süreyle vitamin D uygulanan hippokampal nöronların iNOS mRNA seviyelerinin kontrol gruplarına kıyasla anlamlı derecede düştüğü saptandı (p<0,001). Ayrıca, vitamin D uygulamasının sitotoksiste belirteci olan LDH salınımını da azalttığı saptandı (p<0,001). So­nuç: Sonuçlarımız, vitamin D’nin iNOS anlatımındaki artışı engelleyerek, hippokampal nöronları oksidatif hasara karşı koruyabileceğini göstermektedir.

🔖

Cite This Article

DURSUN, E., GEZEN, D. A., YILMAZER, S. (2014). The influence of vitamin d treatment on the ınducible nitric oxide synthase (ınos) expression in primary hippocampal neurons. Nöropsikiyatri Arşivi, Cilt: 51 - Sayı: 2, 163–168. https://ajindex.com/articles/292460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Squire LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99:195-231
  2. Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 2011; 6:85
  3. Hardy J. Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci 1997; 20:154-159
  4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 2002; 297:353-356
  5. Nathan C, Calingasan N, Nezezon J, Ding A, Lucia MS, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF. Protection from Alzheimer’s-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 2005; 202:1163-1169
  6. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 2004; 44:181-193
  7. Moore AH, O’Banion MK. Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease. Adv Drug Deliv Rev 2002; 54:1627-1656
  8. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O’Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer’s disease. Neurobiol Aging 2000; 21:383-421
  9. Lee YB, Nagai A, Kim SU. Cytokines, chemokines and cytokine receptors in human microglia. J Neurosci Res 2002; 69:94-103
  10. Fernández-Vizarra P, Fernández AP, Castro-Blanco S, Encinas JM, Serrano J, Bentura ML, Muñoz P, Martínez-Murillo R, Rodrigo J. Expression of nitric oxide system in clinically evaluated cases of Alzheimer’s disease. Neurobiol Dis 2004; 15:287-305
  11. Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, Riederer P, Feinstein DL, Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:906-916
  12. Lüth HJ, Münch G, Arendt T. Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation. Brain Res 2002; 953:135-143
  13. Wong A, Lüth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Münch G. Advanced glycation endproducts co-localize with inducible nitric oxide s